HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lysylvaline (Lys-Val)

Also Known As:
Lys-Val; lysyl-valine
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Abid, Karim Alexandre: 1 article (09/2020)
2. Del Pozzo, Luigi: 1 article (09/2020)
3. Fani, Melpomeni: 1 article (09/2020)
4. Grouzmann, Eric: 1 article (09/2020)
5. Mansi, Rosalba: 1 article (09/2020)
6. Nicolas, Guillaume Pierre: 1 article (09/2020)
7. Banerjee, Sharmila: 1 article (08/2004)
8. Chakraborty, Sudipta: 1 article (08/2004)
9. Das, Tapas: 1 article (08/2004)
10. Korde, Aruna: 1 article (08/2004)

Related Diseases

1. Hemorrhage
2. Neoplasms (Cancer)
09/11/2020 - "Aiming to target a broader spectrum of tumors, we evaluated the bis-iodo-substituted somatostatin analog ST8950 ((4-amino-3-iodo)-d-Phe-c[Cys-(3-iodo)-Tyr-d-Trp-Lys-Val-Cys]-Thr-NH2), having subnanomolar affinity for SST2 and SST5, labeled with [177Lu]Lu3+ via the chelator DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). "
08/01/2004 - "Lanreotide, [beta-naphthyl-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2] a disulfide-linked cyclic octapeptide and a somatostatin analog, reported to bind with a wide variety of tumors expressing somatostatin receptors, was conjugated with DOTA. "
01/01/1992 - "The effects of treatment with a bombesin receptor antagonist [D-Tpi6, Leu13 psi (CH2NH) Leu14]BN(6-14)(RC-3095) and the combination of an agonist of luteinizing hormone-releasing hormone [D-Trp6]-LH-RH and somatostatin analog D-Phe-Cys-Tyr-D-Trp-Lys-Val- Cys-Trp-NH2 (RC-160) were studied in nude mice bearing xenografts of the hormone-dependent human prostate tumor PC-82. "
05/01/1997 - "Rhenium-188-labeled hydroxyethylidenediphosphonate (HEDP) and Re-188-dimercaptosuccinic acid (DMSA) are being applied for palliative treatment of pain associated with skeletal metastases, and the Re-188-RC-160 somatostatin analogue [cyclic NH2-(D)-Phe-Cys-Try-(D)-Trp-Lys-Val-Cys-Trp-NH2] for somatostatin-receptor-positive tumors. "
11/05/1982 - "The primary structure of the tumor-derived peptide is H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala- Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly -Ala-Arg-Ala-Arg-Leu-NH2. "
3. Thyroid Neoplasms (Thyroid Cancer)
4. Pain (Aches)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Somatostatin (Somatotropin Release-Inhibiting Factor)
2. Adrenocorticotropic Hormone (ACTH)
3. alanyltyrosine
4. Peptides (Polypeptides)
5. Somatostatin Receptors (Somatostatin Receptor)
6. arginyl-glutamine
7. glutaminyl-glycine (Gln-Gly)
8. arginyllysine
9. cysteinyltyrosine
10. 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Related Therapies and Procedures

1. Intraventricular Infusions
2. Palliative Care (Palliative Therapy)